This federal contract award, with a ceiling value of $1,651.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used for diabetes management.
The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.
The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about major subcontractors. The contract has an ultimate completion date of December 4, 2024.
Generated 3/4/25, 11:38 AM